Pharmaceutical business in the US is one of the key sectors of the economy, characterized by a high level of innovation, strict regulatory standards and significant investment in research and development. Our website offers articles that discuss key aspects of the pharmaceutical industry in the US, including innovations in drug therapies and biotechnology.
Explore how companies are overcoming regulatory barriers and utilizing new technologies to develop drugs. Learn about the impact of federal and state laws on pharma company operations and drug pricing mechanisms. Gain insight into the strategies that pharmaceutical companies are employing to expand their presence in both domestic and international markets. Explore the challenges and opportunities that await the U.S. pharmaceutical industry as it continues to lead globally in medical innovation.
Are you one of the millions of people struggling with obesity and sleep apnea? You’re not alone. According to the National Sleep Foundation, an estimated over a hundred million people suffer from sleep apnea, with many more cases going undiagnosed. But now, there’s hope on the horizon in the form of Eli Lilly‘s groundbreaking new […]
Eli Lilly’s Miracle Drug: Lose Weight and Sleep Like a Baby with Zepbound! Read More »
A study has shown that a vibrating tablet can give people on a diet a feeling of satiety. It convinces the brain that the person has recently eaten.
A bioelectronic weight loss pill has been created in the US Read More »
Smart mini-clinics have opened in the US, where all services are provided by artificial intelligence.
AI instead of doctors: smart medical offices have appeared in the U.S. Read More »
This was discussed during a meeting in Washington with USAID Deputy Director of Public Health James Meloni, USAID Special Advisor for Ukraine Reconstruction Alex Tersky, Ukraine Monitoring and Evaluation Officer Kai Printup and other USAID partners
USAID has expressed interest in introducing KPIs for family doctors in Ukraine Read More »
The proposal has already been sent to the White House Office of Management and Budget for final review The intent to ban the sale of menthol cigarettes and flavored cigars was first announced by the U.S. Food and Drug Administration in April 2023. The rationale for this restriction was the potential reduction in morbidity and
FDA plans to ban menthol cigarettes in the near future Read More »
Data from a study conducted in the US and Europe showed that drug consumers are more than interested in large pharmaceutical companies disclosing information about the carbon footprint of the drugs they produce
Gilead Sciences commits to pay $246.75 million to customers who have purchased Atripla or Truvada, or generic versions of these drugs over the past five years
This is a project for the localization of biotechnology drugs, which involves contract manufacturing on the basis of existing pharmaceutical production facilities in Kazakhstan
Pfizer plans to localize its production in Kazakhstan Read More »
In a move that could reverberate across the Atlantic, a U.S. FDA advisory panel has unanimously declared that oral phenylephrine, a common ingredient in over-the-counter (OTC) cold medications, is ineffective for relieving nasal congestion. This decision could have implications for European consumers and regulators, as phenylephrine is also a staple in many European cold remedies.
The Phenylephrine Paradox: What a U.S. FDA Decision Could Mean for Europe Read More »
A blood test developed at the University of Washington School of Medicine has proven to be very accurate in detecting early signs of Alzheimer’s disease.
New blood test for Alzheimer’s disease confirmed accurate in clinical trial Read More »
